Consolidated Statement of Cash Flows - USD ($)	3 Months Ended				12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021	Sep. 30, 2021	Dec. 31, 2020	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2020
Cash flows from operating activities:
Net Loss	$ (14,631,432)	$ (19,160,904)		$ (9,395,621)	$ (70,083,693)	$ (23,394,889)
Adjustments to reconcile net (income) loss to net cash used by operating activities:
Stock based compensation					555,215	1,298,106
Restricted stock expense					373,610	1,626,613
Marketing stock amortization					907,774	871,390
Issuance of stock / warrants for service					0	97,720
Inventory and materials impairment		878,142			878,142	670,580
Intangibles amortization					884,380	0
Depreciation					948,962	1,017,408
Impairment of goodwill and other intangible assets					60,955,970	0
Gain on sale of fixed assets					(322,017)	0
Increase/(Decrease) in contingent liability					(8,473,999)	6,687,439
Realized and unrealized loss (gain) of Marketable and other securities					33,350	(546,878)
Termination benefit					0	196,896
Extinguishment of Paycheck Protection Program Loan					0	(1,466,113)
Amortization of operating lease asset					1,137,119	1,236,397
Changes in operating assets and liabilities:
Accounts receivable					65,541	(183,735)
Deposits					284,977	261,125
Inventory					(112,189)	(1,009,192)
Prepaid inventory					40,060	(263,341)
Prepaid expenses and other current assets					(289,586)	525,670
Accounts payable and accrued expenses					(1,812,547)	(104,422)
Operating lease liability					(1,151,152)	(1,159,097)
Deferred revenue / customer deposits					203,341	3,723
Collection on discontinued operations accounts receivable					9,592	436,167
Deferred tax liability					0	(895,000)
Cash used by operating activities					(14,967,150)	(14,093,433)
Cash flows from investing activities:
Proceeds from sale of other investment securities					0	540,000
Purchase of other investment securities					0	(750,000)
Purchase of DirectCBDOnline.com					0	(2,000,000)
Purchase of property and equipment					(688,680)	(342,013)
Cash provided (used) by investing activities					(688,680)	(2,552,013)
Cash flows from financing activities:
Proceeds from issuance of common stock					0	0
Proceeds from issuance of preferred stock					0	30,938,386
Note payable					(33,355)	(151,551)
Preferred dividend distribution					(4,002,005)	(2,554,609)
Deferred Issuance costs					0	0
Cash provided by financing activities					(4,035,360)	28,232,226
Net increase (decrease) in cash					(19,691,190)	11,586,780
Cash and cash equivalents, beginning of period		$ 26,411,424		$ 14,824,644	26,411,424	14,824,644
Cash and cash equivalents, end of period	$ 6,720,234		$ 26,411,424		$ 6,720,234	26,411,424	$ 14,824,644
Interest expense						2,364	33,693
Warrants to Purchase Common Stock [Member] | Representative of the Underwriters [Member]
Non-cash financial/investing activities:
Warrants issued to representative						0	524,113
Common Stock Earnout Shares [Member]
Non-cash financial/investing activities:
Issuance of Contingent earnout shares:						$ 1,086,000	$ 4,620,000